Orbital cellulitis medical therapy: Difference between revisions
No edit summary |
|||
Line 6: | Line 6: | ||
Orbital cellulitis is considered an ophthalmological emergency.Prompt treatment is vital for a patient when fighting orbital cellulitis. Treatment typically involves IV antibiotics in the hospital and frequent observation (every 4-6 hours). Along with this several laboratory tests are run including a complete blood count, differential, and blood culture. | Orbital cellulitis is considered an ophthalmological emergency.Prompt treatment is vital for a patient when fighting orbital cellulitis. Treatment typically involves IV antibiotics in the hospital and frequent observation (every 4-6 hours). Along with this several laboratory tests are run including a complete blood count, differential, and blood culture. | ||
==Medical Therapy== | ==Medical Therapy== | ||
* ''' | * '''Antimicrobial Therapy''' | ||
*'''1. Empiric antimicrobial therapy''' | |||
:*Preferred regimen (1): [[Ampicillin]]/[[Sulbactam]] 3 g IV q6h for 1 week | |||
:*Preferred regimen (2): [[Ceftriaxone]] 1-2 g IV q12h for 1 week | |||
:*Preferred regimen (3): [[Clindamycin]] 300 mg IV q6h for 1 week | |||
:* Preferred regimen (4): [[Nafcillin]] 2 g IV q4h for 1 week {{and}} [[Ceftriaxone]] 2 g IV q24h for 1 week {{and}} [[Metronidazole]] 30-35 mg/kg/d IV divided in 3 doses for 1 week | |||
:* Alternative regimen (1), MRSA suspicion: [[Vancomycin]] 1 g IV q12h for 1 week {{and}} [[Ceftriaxone]] 2 g IV q24h for 1 week {{and}} [[Metronidazole]] 30-35 mg/kg/d IV divided q8h for 1 week | |||
:* Alternative regimen (2), MRSA suspicion: [[Vancomycin]] 1 g IV q12h for 1 week {{and}} [[Levofloxacin]] 750 mg IV q24h for 1 week {{and}} [[Metronidazole]] 30-35 mg/kg/d IV divided q8h for 1 week | |||
:*Alternative regimen (3), pediatric: [[Ampicillin]]/[[Sulbactam]] 200-300 mg/kg/d IV divided q6h for 1 week | |||
:*Alternative regimen (4), pediatric: [[Ceftriaxone]] 100 mg/kg/d IV divided q12h for 1 week | |||
:*Alternative regimen (5), pediatric: [[Clindamycin]] 20-40 mg/kg/d IV divided q12 for 1 week | |||
:*Note (1): Oral antibiotic therapy may be extended beyond 2-3 weeks if the clinical presentation is consistent with either severe sinusitis or bony destruction | |||
:*Note (2): Consider surgical intervention if the patient has either visual loss, complete ophthalmoplegia, large abscess > 1 cm, or no clinical improvement following 1-2 days of antibiotic administration | |||
*'''2. Pathogen-directed antimicrobial therapy''' | |||
:*'''2.1 Methicillin-resistant staphylococcus aureus (MRSA)''' | |||
::*Preferred regimen (1): [[Vancomycin]] 1 g IV q12h for 1 week {{and}} [[Ceftriaxone]] 2 g IV q24h for 1 week {{and}} [[Metronidazole]] 30-35 mg/kg/d IV divided q8h for 1 week | |||
::*Preferred regimen (2): [[Vancomycin]] 1 g IV q12h for 1 week {{and}} [[Levofloxacin]] 750 mg IV q24h for 1 week {{and}} [[Metronidazole]] 30-35 mg/kg/d IV divided q8h for 1 week | |||
:*'''2.2 Non-MRSA organisms''' | |||
::*Preferred regimen (1): [[Ampicillin]]/[[Sulbactam]] 3 g IV q6h for 1 week | |||
::*Preferred regimen (2): [[Ceftriaxone]] 1-2 g IV q12h for 1 week | |||
::*Preferred regimen (3): [[Clindamycin]] 300 mg IV q6h for 1 week | |||
::*Preferred regimen (4): [[Nafcillin]] 2 g IV q4h for 1 week {{and}} [[Ceftriaxone]] 2 g IV q24h for 1 week {{and}} [[Metronidazole]] 30-35 mg/kg/d IV divided in 3 doses for 1 week | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 13:01, 12 August 2015
Orbital cellulitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Orbital cellulitis medical therapy On the Web |
American Roentgen Ray Society Images of Orbital cellulitis medical therapy |
Risk calculators and risk factors for Orbital cellulitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Because of concern for spread of infection, patients must be admitted to the hospital to receive intravenous antibiotics. Orbital cellulitis is considered an ophthalmological emergency.Prompt treatment is vital for a patient when fighting orbital cellulitis. Treatment typically involves IV antibiotics in the hospital and frequent observation (every 4-6 hours). Along with this several laboratory tests are run including a complete blood count, differential, and blood culture.
Medical Therapy
- Antimicrobial Therapy
- 1. Empiric antimicrobial therapy
- Preferred regimen (1): Ampicillin/Sulbactam 3 g IV q6h for 1 week
- Preferred regimen (2): Ceftriaxone 1-2 g IV q12h for 1 week
- Preferred regimen (3): Clindamycin 300 mg IV q6h for 1 week
- Preferred regimen (4): Nafcillin 2 g IV q4h for 1 week AND Ceftriaxone 2 g IV q24h for 1 week AND Metronidazole 30-35 mg/kg/d IV divided in 3 doses for 1 week
- Alternative regimen (1), MRSA suspicion: Vancomycin 1 g IV q12h for 1 week AND Ceftriaxone 2 g IV q24h for 1 week AND Metronidazole 30-35 mg/kg/d IV divided q8h for 1 week
- Alternative regimen (2), MRSA suspicion: Vancomycin 1 g IV q12h for 1 week AND Levofloxacin 750 mg IV q24h for 1 week AND Metronidazole 30-35 mg/kg/d IV divided q8h for 1 week
- Alternative regimen (3), pediatric: Ampicillin/Sulbactam 200-300 mg/kg/d IV divided q6h for 1 week
- Alternative regimen (4), pediatric: Ceftriaxone 100 mg/kg/d IV divided q12h for 1 week
- Alternative regimen (5), pediatric: Clindamycin 20-40 mg/kg/d IV divided q12 for 1 week
- Note (1): Oral antibiotic therapy may be extended beyond 2-3 weeks if the clinical presentation is consistent with either severe sinusitis or bony destruction
- Note (2): Consider surgical intervention if the patient has either visual loss, complete ophthalmoplegia, large abscess > 1 cm, or no clinical improvement following 1-2 days of antibiotic administration
- 2. Pathogen-directed antimicrobial therapy
- 2.1 Methicillin-resistant staphylococcus aureus (MRSA)
- Preferred regimen (1): Vancomycin 1 g IV q12h for 1 week AND Ceftriaxone 2 g IV q24h for 1 week AND Metronidazole 30-35 mg/kg/d IV divided q8h for 1 week
- Preferred regimen (2): Vancomycin 1 g IV q12h for 1 week AND Levofloxacin 750 mg IV q24h for 1 week AND Metronidazole 30-35 mg/kg/d IV divided q8h for 1 week
- 2.2 Non-MRSA organisms
- Preferred regimen (1): Ampicillin/Sulbactam 3 g IV q6h for 1 week
- Preferred regimen (2): Ceftriaxone 1-2 g IV q12h for 1 week
- Preferred regimen (3): Clindamycin 300 mg IV q6h for 1 week
- Preferred regimen (4): Nafcillin 2 g IV q4h for 1 week AND Ceftriaxone 2 g IV q24h for 1 week AND Metronidazole 30-35 mg/kg/d IV divided in 3 doses for 1 week